Medical Economics December 2, 2024
Richard Payerchin

Key Takeaways

  • Side effects of GLP-1 RA drugs influence patient adherence, despite controlled research guiding physicians.
  • Real-world experiences may lead to treatment discontinuation due to physical side effects.
  • Cost and availability significantly impact patient willingness to continue treatment.
  • Robert Kushner, MD, highlights these factors based on his expertise in obesity and nutrition.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

Side effects play a role in a patient’s desire to use GLP-1 RA drugs for weight loss or other health conditions....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Pharma / Biotech, Physician, Provider, Trends
A New Dogma Of Molecular Biology: A Paradigm Shift
Will weight-loss drugs soon be covered by Medicare and Medicaid?
New EU Health Commissioner on biotech, AI, MDR, HTA and cybersecurity
New insights into how cells generate microRNAs
How much insurers pay for weight loss drugs

Share This Article